Description review

AmpSeq programme Director

LGC Group · United States · back to the listing

HR standards

26/100

poor

Title ↔ description

59/100

needs work

Reads as

Unclear

no confident match

What the listing never says

  • No section describes what the person would actually do. Scope clarity

The listing, marked up

What we offer (US based-employees):

• Competitive compensation with strong bonus program

• Comprehensive medical, dental, and vision benefits for employees and dependents

• FSA/HSA Pre-tax savings plans for health care, childcare, and elder care

• Deductible Buffer Insurance and Critical Illness Insurance

• 401(k) retirement plan with matching employer contribution

• Company-paid short- and long- term disability, life insurance, and employee assistance program

• Flexible work options

• Pet Insurance for our furry friends

• 8 weeks of Parental Leave for qualifying life events

• PTO that begins immediately

• Town Hall monthly meeting onsite/virtual, Cheer program where employees are recognized for outstanding work, Company wide social events, frequent catered lunches and much more!

LGC strongly believes that every job applicant and employee should be valued for their individual talents regardless of age, disability, race, color, ethnic or national origin, sex, sexual orientation, gender reassignment, marital or civil partnership, pregnancy or maternity, religion, or belief. Short listing, interviewing and selection will always be carried out without regard to gender, sexual orientation, marital status, color, race, nationality, ethnic or national origins, religion or belief, age, or trade union membership.

All your information will be kept confidential according to EEO guidelines.

This position requires current U.S. work authorization. We are unable to sponsor or assume sponsorship for temporary visas (including H‑1B, H‑2B, OPT, O‑1, TN)

LGC is a leading, global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments. Our high-quality product portfolio is comprised of mission-critical tools for genomic analysis and for quality assurance applications, which are typically embedded and recurring within our customers’ products and workflows and are valued for their performance, quality and range.

Our tools play a key role in customer workflows from discovery applications through to commercial manufacture and enable its customers to: bring new diagnostics and therapies to market; progress research and development; optimize food production; and continuously monitor and enhance the quality of food, the environment and consumer products.

LGC’s 1 75+ years1 of scientific heritage, combined with a track record of innovation and value-enhancing acquisitions, has enabled the company to build its product portfolio and expertise, and develop deep relationships with customers, industry partners and the global scientific community. Join us and help us achieve our mission of Science for a Safer World!

Our kit and component manufacturing sites are situated across the US (Middleton, Petaluma, and Novato) and Europe (Berlin and Lystrup) and are underpinned by either ISO 13485 or ISO 9001 compliance. These capabilities support a wide portfolio of off-the-shelf components and kits critical to NGS workflows including magnetic beads, oligos, enzymes, and library prep kits. Additionally, our primary manufacturing capabilities enable customization and bulk (OEM) manufacture of reagents such as key NGS enzymes for high volume applications.

Originally posted on Himalayas

How this was produced

Highlights are found by rule, not by a model: each one is a phrase matched at a known position, and every note is a template we wrote. The two scores come from a typed-decision model (Jev) that reads the listing against the official role definition and real listings for the same role, and returns probabilities rather than prose — it never writes any of the words on this page, and never chooses what to highlight.

Deterministic penalty applied to the HR score: 16 points (from 42 before penalties). Reviewed 30 Sep 2026.